214 related articles for article (PubMed ID: 12840219)
1. Vitamin D-3 receptor as a target for breast cancer prevention.
Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer.
Welsh J; Wietzke JA; Zinser GM; Smyczek S; Romu S; Tribble E; Welsh JC; Byrne B; Narvaez CJ
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):85-92. PubMed ID: 12650704
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and breast cancer: insights from animal models.
Welsh J
Am J Clin Nutr; 2004 Dec; 80(6 Suppl):1721S-4S. PubMed ID: 15585794
[TBL] [Abstract][Full Text] [Related]
6. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
7. Function of the vitamin D endocrine system in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D(3) receptor ablation alters mammary gland morphogenesis.
Zinser G; Packman K; Welsh J
Development; 2002 Jul; 129(13):3067-76. PubMed ID: 12070083
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
11. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolism in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D receptor in cancer.
Thorne J; Campbell MJ
Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
[TBL] [Abstract][Full Text] [Related]
16. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.
Johnson AL; Zinser GM; Waltz SE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E674-85. PubMed ID: 25139050
[TBL] [Abstract][Full Text] [Related]
17. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice.
Zinser GM; Welsh J
Mol Endocrinol; 2004 Sep; 18(9):2208-23. PubMed ID: 15178742
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and breast cancer: emerging concepts.
Mehta RG; Peng X; Alimirah F; Murillo G; Mehta R
Cancer Lett; 2013 Jun; 334(1):95-100. PubMed ID: 23142286
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
Valrance ME; Brunet AH; Welsh J
Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
[TBL] [Abstract][Full Text] [Related]
20. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]